×
Join Our Mailing List

 

 

2023 Archived Content

Mark your calendar for OPT Congress returning to Boston, March 13-14, 2024.

Sign up for updates

Thank you for a record-breaking year, we look forward to seeing you in 2024 at our new, larger location—The Seaport Hotel Boston!

View 2023 Image Gallery
View 2023 Videos

Welcome to OPT Congress!

OPT Congress is the premier conference for professionals involved in discovering and developing oligonucleotide therapeutics. Now in its 8th year, this unique event brings together leading discovery scientists, developers, CMC experts, regulatory specialists and technology providers to discuss advances in next-generation oligonucleotide and precision therapeutics throughout the drug development process. New this year, we are delighted to announce a third conference program dedicated to Emerging mRNA Therapeutics to complement our established Oligo Discovery & Delivery and CMC & Regulatory programs. In addition to 2 days of inspiring keynotes, interactive discussions and more than 55 scientific presentations, we deliver an in-depth course focusing on the Safety & Toxicity of Nucleic Acids. Join your peers and industry experts as together we optimize drug design, delivery and performance, accelerate time to market and achieve commercial success.

View Program
Sponsor and Exhibit Opportunities
2022 Event Highlights
3 Conferences
55+ Speakers
250+ Attendees
130+ Unique Organizations
65% of Attendees from Biotech
15% of Attendees from Pharma

2023 Plenary Speakers

Marvin Caruthers, PhD

Marvin Caruthers, PhD
Distinguished Professor, University of Colorado

Rubina Parmar, PhD

Rubina Parmar, PhD
Vice President, Chemistry & Delivery Sciences, Intellia Therapeutics, Inc.

Arthur Levin, PhD

Arthur Levin, PhD
CSO, Avidity Biosciences

Daniel Anderson, PhD

Daniel Anderson, PhD
Professor, Chemical Engineering, Massachusetts Institute of Technology

Mano Manoharan, PhD

Mano Manoharan, PhD
Distinguished Scientist & Senior Vice President, Innovation Chemistry, Alnylam Pharmaceuticals

Steve Pascolo, PhD

Steve Pascolo, PhD
Senior Scientist, University Hospital of Zurich; Founder & CEO, Miescher Pharma GmbH


Our Executive Advisory Board

Dmitry Samarsky, PhD

Dmitry Samarsky, PhD
CTO, Sirnaomics

Muthiah (Mano) Manoharan, PhD

Muthiah (Mano) Manoharan, PhD
Senior Vice President, Drug Discovery, Alnylam Pharmaceuticals

Arthur Levin, PhD

Arthur Levin, PhD
CSO, Avidity Biosciences

Lubo Nechev, PhD

Lubo Nechev, PhD
Vice President Process and Analytical Sciences, Alnylam Pharmaceuticals

Ekkehard Leberer, PhD

Ekkehard Leberer, PhD
Senior Life Sciences Consultant, ELBIOCON

Key Contacts: Get Involved with OPT Congress

Gemma Smith

For more information on the conference, please contact:
Gemma Smith
Senior Conference Director
Cambridge Healthtech Institute
+44 (0)7754-518-131
Email: Gemma Smith

Kristin Skahan

For sponsorship information, please contact:
Kristin Skahan
Sr. Business Development Manager
Cambridge Healthtech Institute
(+1) 781-972-5431
Email: Kristin Skahan

Ellen Farrar

For media and association partnerships, please contact:
Ellen Farrar
Senior Marketing Manager
Cambridge Healthtech Institute
(+1) 781-972-5492
Email: Ellen Farrar